PIPr Therapeutics
PrivateLast Round
Series A
Extension
Mar 1, 2021
Total Funding Raised
$23M
Company Overview
PIPr Therapeutics is a biotechnology company that develops small molecule inhibitors targeting metalloproteases for the treatment of inflammatory and immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIPr Therapeutics Comparables
Compare PIPr Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 80% | |
| Symberix, Inc. | 80% | |
| Giiant Pharma Inc. | 76% | |
PIPr Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2021 | ||||
| Series A | Jun 10, 2019 |
PIPr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A Extension |
| Hatteras Venture Partners | Series A, Series A Extension |
| Osage University Partners | Series A, Series A Extension |
| Elm Street Ventures | Series A, Series A Extension |
| Johnson & Johnson Innovation – JJDC | Series A |
| Malin PLC | Series A |
PIPr Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PIPr Therapeutics's valuation, stock price, and market status.